Navigation Links
Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
Date:4/30/2008

at EURO 342 million due to the ongoing introduction of generic versions of the product in Europe, and especially in France. In the Other Countries region, the product recorded strong growth of 27.8%, to EURO 46 million.

The efficacy results from the EORTC (European Organization for Research and Treatment of Cancer) EPOC Intergroup study were published in the Lancet in March. These results showed that in eligible patients, Eloxatin(R) in combination with 5-fluorouracil/leucovorin (a chemotherapy regimen called FOLFOX4) significantly improved progression-free survival compared to surgery alone when given perioperatively (before and after surgery) to colorectal cancer patients with initially resectable liver metastases.

Net sales of Tritace(R), affected by competition from generics in Canada and Europe, fell by 34.9% to EURO 138 million.

Net sales of Acomplia(R) were EURO 22 million.

In March, the National Institute for Health and Clinical Excellence (NICE) -- the organization responsible for providing national guidance on the prevention and treatment of ill health in England and Wales -- recommended the use of Acomplia(R) within its licensed indications as an adjunct to diet and exercise for adults who are obese or overweight and who have had an inadequate response to, are intolerant of, or are contraindicated to other anti-obesity agents previously reviewed by NICE.

Xyzal(R), a new prescription oral antihistamine, was launched by sanofi-aventis and UCB in the United States at the start of October 2007. The product reported 2008 first-quarter sales of EURO 18 million. On February 19, UCB and sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) had approved Xyzal(R) oral solution for the relief of seasonal and year round allergies and chronic idiopathic urticaria.

Worldwide presence of Plavix(R) / Iscover(R)

EURO million Q1 2008 Change on a comparable basis

Europe
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Tubbs Jones Introduces Resolution Encouraging STD Prevention
2. New electronic health records demonstration project encouraging step says ACP
3. Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates
4. Digirad Corporation Reports Financial Results for First-Quarter 2008
5. Essilors 2008 First-Quarter Report
6. First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
7. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
8. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
9. VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Abbott Hosts Conference Call for First-Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... This year, in recognition of IAM, ... (FIRST) will publish a unique awareness campaign featuring real-life ... the month of May and carry the message, "Be ... The positioning was chosen to encourage the general public ... to help support our mission of educating, inspiring and ...
(Date:4/21/2015)... Approximately 75 million Americans live in areas with ... (EPA). On top of this, consuming alcohol and exposure ... of toxins found in the body. A natural way ... to increase consumption of broccoli. Considered by many as ... – a long-lasting antioxidant – of all cruciferous vegetables. ...
(Date:4/21/2015)... 2015 As a provider of holistic, ... that their rehabilitation strategy, which involves various treatment modalities, ... In an effort to offer hope and encouragement to ... lives, Best Drug Rehabilitation has featured a series of ... successful graduates of their recovery program. , One ...
(Date:4/21/2015)... 21, 2015 Zane Benefits, the leader ... today the publication of a new guide “Health Reimbursement ... changes to the health insurance industry, including how employers ... to question what is permitted when implementing an HRA. ... owners determine which HRAs are compliant this year. ...
(Date:4/21/2015)... Utah (PRWEB) April 21, 2015 Zane ... businesses, announced today its CEO Rick Lindquist has been ... for 2015. , According to Rick Lindquist, “There is ... industry, and Zane Benefits’ small business solutions are at ... recognition provided by Employee Benefit Adviser’s Rising Stars.” , ...
Breaking Medicine News(10 mins):Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Best Drug Rehabilitation Graduate Discusses Making Amends and Rebuilding Relationships 2Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2
... trend towards illicit use of drugs is on the rise ... 400,000 admissions to the emergency department each year. , ... visiting the emergency department of a hospital in South West ... asked to assess the need for treatment with special reference ...
... new evidence shows the high fat, low carb diet promoted ... simply the Atkins' diet) could damage the heart., ... // carbohydrates directly affected the heart's ability to store energy. ... from the Cardiac Metabolism Research Group of Oxford University looked ...
... you know that heart disease is ranked as the ... to a new, simple test called dobutamine stress echocardiography ... // , ,The study has been conducted among ... 75. The study participants underwent a certain type of ...
... have found that drinking and eating sweets may reduce ... produced in the body when the 0person is under ... responsible for increase in weight and obesity. The researchers ... hormone level is reduced causing no increase in weight ...
... Professor Ted Laurence, Lawrence Livermore National Laboratory are studying ... mechanism of protein folding. The new theory on protein ... is incorrectly folded which leads to diseases and the ... of the National Academy of Sciences. , ,The ...
... jailed for life for bludgeoning his friend Stuart Robertson to ... , ,He attacked his friend less than a year ... judge had ordered he be detained indefinitely for another violent ... Glasgow, befriended James Smith while they were both patients at ...
Cached Medicine News:Health News:Heart damage a consequence of Atkins’ Die 2Health News:A Simple Test To Detect Heart Disease In Women Can Be Lifesaving 2Health News:Man Bludgeons Friend, Gets Life Term 2
(Date:4/21/2015)... , April 21, 2015 Workers, compensation ... 5.4 percent decrease in utilization helped offset a 7 ... new data released today by Express Scripts (NASDAQ: ... Workers, Compensation Drug Trend Report discusses the overall pharmacy ... among injured workers. Opioid Management Mitigates ...
(Date:4/21/2015)... , April 21, 2015  TissueGene, Inc. a ... therapies in the field of cell therapy, today ... the position of Chief Operating Officer.  Mr. Newman ... Management & Clinical Operations at ZIOPHARM Oncology, a ... employing novel gene expression, control and cell technologies ...
(Date:4/21/2015)... and PARIS and BURLINGTON, N.C. ... (NYSE: DGX ), the world,s leading ... French National Institute of Health and Medical Research ... initiative they co-founded to provide scientists and laboratory ... BRCA1 and BRCA2 genetic data. The program,s goal ...
Breaking Medicine Technology:Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 2Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 4TissueGene, Inc. Hires Robert Newman as Chief Operating Officer 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 2Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 3Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 4Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 5Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 6Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers 7
... HUNTINGTON BEACH, California and AMSTERDAM, ... diagnostics, announced today that,the US Food and Drug Administration ... ages. MammaPrint is the only FDA-cleared,breast cancer recurrence test ... the FDA has issued four clearances for MammaPrint, covering,all ...
... , SAN DIEGO, Dec. 17 Suneva Medical, a ... signed a multi-million dollar line of credit facility with Western ... be used to fund commercial support for Artefill®, the only ... well as to expand Suneva,s Aesthetic Market growth objectives. , ...
Cached Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3
The SYNCHRON CX7-S workstation offers a broad menu, advanced data management and more. Targeted to the mid-volume lab, the CX7-S is easy to use, easy to maintain and easy to acquire....
... workstation offers a broad menu, ... the mid-size lab that processes ... day. Like all SYNCHRON CX-S ... to use, easy to maintain ...
... for the high-volume lab, the SYNCHRON LX4201 ... performing up to 2,880 tests per hour. ... the SYNCHRON LX4201 with broad menu, speed ... you've come to expect from Beckman Coulter-innovative, ...
... technology to increase laboratory efficiency ... lower costs. It takes the ... features that you will not ... analyzer, including closed tube sampling ...
Medicine Products: